TREAT: Darbepoetin alfa does not reduce outcomes of death, CV events or end ... - Cardiology Today |
|
|
Cardiology TodayThe administration of darbepoetin alfa was not associated with a reduction in death, cardiovascular events or end-stage renal disease, according to results ...
|